# Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant

> **NCT03118661** · PHASE1 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- HIV-1-infection

## Interventions

- **OTHER:** For Step 2: Structured treatment interruption
- **PROCEDURE:** Peripheral blood draw

## Key facts

- **NCT ID:** NCT03118661
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-03-19
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No accrual to the study
- **Last updated:** 2018-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03118661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03118661, "Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03118661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*